Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, ?-glucuronidase, ?-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024
“The reporter gene assays market is projected to grow at a CAGR of 10.1%.”
The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2018, at a CAGR of 10.1%. Growth in this market is driven by increasing funding for cell-based research, the growing applications of gene expression, and a rising preference for cell-based assays. However, the high cost of cell biology research is expected to restrain the growth of this market to a certain extent during the forecast period.
By end user, the academic and research institutes segment is projected to have the largest market share during the forecast period (2019–2024).”
On the basis of end user, the reporter gene assays market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and contract research organizations. The academic and research institutes segment is expected to account for the largest share in 2019. The large share of this end-user segment can be attributed to the increasing government initiatives towards drug discovery and life science R&D activities.
“The cell signaling segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of application, the reporter gene assays market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. The cell signaling applications segment is expected to witness the highest CAGR owing to its importance in several cellular functionalities such as cell differentiation, cell fate determination, and cell growth, and advanced applications of cell signaling in life science sectors such as biotechnology, molecular biology, and microbiology.
“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global reporter gene assays market in 2019. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the large population in China and India, rising geriatric population, and increasing incidence of chronic diseases. Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.
The breakdown of primary participants was as mentioned below:
Research Coverage:
The report analyzes the various reporter gene assays products and their adoption pattern. It aims at estimating the market size and future growth potential of the global reporter gene assays market for different segments such as products, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2018, at a CAGR of 10.1%. Growth in this market is driven by increasing funding for cell-based research, the growing applications of gene expression, and a rising preference for cell-based assays. However, the high cost of cell biology research is expected to restrain the growth of this market to a certain extent during the forecast period.
By end user, the academic and research institutes segment is projected to have the largest market share during the forecast period (2019–2024).”
On the basis of end user, the reporter gene assays market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and contract research organizations. The academic and research institutes segment is expected to account for the largest share in 2019. The large share of this end-user segment can be attributed to the increasing government initiatives towards drug discovery and life science R&D activities.
“The cell signaling segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of application, the reporter gene assays market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. The cell signaling applications segment is expected to witness the highest CAGR owing to its importance in several cellular functionalities such as cell differentiation, cell fate determination, and cell growth, and advanced applications of cell signaling in life science sectors such as biotechnology, molecular biology, and microbiology.
“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global reporter gene assays market in 2019. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the large population in China and India, rising geriatric population, and increasing incidence of chronic diseases. Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.
The breakdown of primary participants was as mentioned below:
- By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation: C-level–35%, Director Level–25%, and Others–40%
- By Region: North America–45%, Europe–20%, Asia Pacific–30%, and RoW–5%
Research Coverage:
The report analyzes the various reporter gene assays products and their adoption pattern. It aims at estimating the market size and future growth potential of the global reporter gene assays market for different segments such as products, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global reporter gene assays market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global reporter gene assays market
- Market Development: Comprehensive information on the lucrative emerging regions by product, application, end user, and region
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global reporter gene assays market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global reporter gene assays market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 REPORTER GENE ASSAYS: MARKET OVERVIEW
4.2 REPORTER GENE ASSAYS MARKET: GEOGRAPHIC OVERVIEW (2018)
4.3 REGIONAL MIX: REPORTER GENE ASSAYS MARKET (2019–2024)
4.4 REPORTER GENE ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing funding for cell-based research
5.2.1.2 Growing applications of gene expression
5.2.1.3 Rising preference for cell-based assays
5.2.2 RESTRAINT
5.2.2.1 High cost of cell biology research
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging countries
5.2.3.2 Increasing demand for personalized medicine
6 REPORTER GENE ASSAYS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ASSAY KITS
6.2.1 LUCIFERASE ASSAY KITS
6.2.1.1 Luciferase assays dominate the assay kits market
6.2.2 FLUORESCENT PROTEIN-RELATED ASSAY KITS
6.2.2.1 Fluorescent reporter proteins are useful in studying cellular events
6.2.3 SECRETED EMBRYONIC ALKALINE PHOSPHATASE ASSAY KITS
6.2.3.1 Advantages of SEAP assays over luciferase and CAT counterparts have supported the growth of this segment
6.2.4 CHLORAMPHENICOL ACETYLTRANSFERASE ASSAY KITS
6.2.4.1 A CAT assay is a standard method for assessing promotor expression in transfected cell lines
6.2.5 BETA-GALACTOSIDASE ASSAY KITS
6.2.5.1 Ease of use and rapidity of these assays have contributed to their overall demand
6.2.6 BETA-GLUCURONIDASE ASSAY KITS
6.2.6.1 GUS reporter assays are mainly used for plant gene expression research
6.2.7 OTHER ASSAY KITS
6.3 REAGENTS
6.3.1 INCREASING DEMAND FOR HIGH-QUALITY REAGENTS IN BIOSCIENCES AND BIOTECHNOLOGY HAS DRIVEN REAGENT USE
7 REPORTER GENE ASSAYS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CELL SIGNALING PATHWAYS
7.2.1 CELL SIGNALING PATHWAYS IS THE LARGEST APPLICATION SEGMENT OF THE REPORTER GENE ASSAYS MARKET
7.3 PROMOTER STRUCTURAL AND FUNCTIONAL ANALYSIS
7.3.1 REPORTER GENE ASSAYS ALLOW FOR THE FUNCTIONAL IDENTIFICATION AND CHARACTERIZATION OF PROMOTER AND ENHANCER ELEMENTS
7.4 GENE REGULATION
7.4.1 REPORTER GENE ASSAYS ACTS AS POWERFUL TOOLS IN ANALYZING GENE REGULATIONS
7.5 PROTEIN INTERACTION
7.5.1 REPORTER GENE ASSAYS ARE USED FOR THE IDENTIFICATION AND QUANTITATIVE ANALYSIS OF PROTEIN-PROTEIN INTERACTION
8 REPORTER GENE ASSAYS MARKET, BY END USER
8.1 INTRODUCTION
8.2 ACADEMIC & RESEARCH INSTITUTES
8.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF THE REPORTER GENE ASSAYS MARKET
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.3.1 INCREASING NUMBER OF R&D ACTIVITIES TO DRIVE THE MARKET GROWTH FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.4.1 CROS TO PROVIDE AFFORDABLE OUTLETS FOR COMPANIES AND ACADEMIA TO PURSUE NEW MEDICINES
8.5 HOSPITAL & DIAGNOSTIC LABORATORIES
8.5.1 HIGH PREVALENCE OF CHRONIC DISEASES TO DRIVE THE MARKET GROWTH AMONG HOSPITAL & DIAGNOSTIC LABORATORIES
9 REPORTER GENE ASSAYS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 US dominates the North American reporter gene assays market
9.2.2 CANADA
9.2.2.1 Canada to witness the highest growth in the North American market primarily due to the increasing research activities
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Favorable funding scenario to support market growth in Germany
9.3.2 FRANCE
9.3.2.1 Increasing government investments in proteomics & genomics research to drive market growth
9.3.3 UK
9.3.3.1 Surge in the prevalence of cancer and neurological disorders is driving the adoption of reporter gene assays
9.3.4 ITALY
9.3.4.1 Growing proteomics and genomics research to drive the growth of the reporter gene assays market in Italy
9.3.5 SPAIN
9.3.5.1 Increasing private and public funding for cell-based research and the presence of a strong R&D infrastructure to drive market growth
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 China to register the highest growth in the global reporter gene assays market, primarily due to the large R&D investments in the country
9.4.2 JAPAN
9.4.2.1 Increasing incidence of chronic diseases and growing geriatric population to drive market growth
9.4.3 INDIA
9.4.3.1 Expansion of pharmaceutical companies
9.4.4 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 INCREASING NUMBER OF PROTEOMICS AND GENOMICS RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH IN THE REGION
9.6 MIDDLE EAST & AFRICA
9.6.1 SEVERAL LEADING GLOBAL PLAYERS ARE FOCUSING ON EXPANDING THEIR PRESENCE IN THE MEA REGION
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.2.1 MARKET SHARE ANALYSIS: REPORTER GENE ASSAYS MARKET
10.3 COMPETITIVE LEADERSHIP MAPPING
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 DYNAMIC DIFFERENTIATORS
10.3.4 EMERGING COMPANIES
10.4 COMPETITIVE SITUATION AND TRENDS
10.4.1 EXPANSIONS
10.4.2 ACQUISITIONS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 MERCK KGAA
11.2 THERMO FISHER SCIENTIFIC, INC.
11.3 PROMEGA CORPORATION
11.4 PERKINELMER
11.5 ABCAM PLC
11.6 BECTON, DICKINSON AND COMPANY
11.7 BIO-RAD LABORATORIES
11.8 DANAHER CORPORATION
11.9 BIOTIUM
11.10 PROMOCELL
11.11 INVIVOGEN
11.12 GENO TECHNOLOGY, INC.
11.13 GENECOPOEIA, INC.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 REPORTER GENE ASSAYS: MARKET OVERVIEW
4.2 REPORTER GENE ASSAYS MARKET: GEOGRAPHIC OVERVIEW (2018)
4.3 REGIONAL MIX: REPORTER GENE ASSAYS MARKET (2019–2024)
4.4 REPORTER GENE ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing funding for cell-based research
5.2.1.2 Growing applications of gene expression
5.2.1.3 Rising preference for cell-based assays
5.2.2 RESTRAINT
5.2.2.1 High cost of cell biology research
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging countries
5.2.3.2 Increasing demand for personalized medicine
6 REPORTER GENE ASSAYS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ASSAY KITS
6.2.1 LUCIFERASE ASSAY KITS
6.2.1.1 Luciferase assays dominate the assay kits market
6.2.2 FLUORESCENT PROTEIN-RELATED ASSAY KITS
6.2.2.1 Fluorescent reporter proteins are useful in studying cellular events
6.2.3 SECRETED EMBRYONIC ALKALINE PHOSPHATASE ASSAY KITS
6.2.3.1 Advantages of SEAP assays over luciferase and CAT counterparts have supported the growth of this segment
6.2.4 CHLORAMPHENICOL ACETYLTRANSFERASE ASSAY KITS
6.2.4.1 A CAT assay is a standard method for assessing promotor expression in transfected cell lines
6.2.5 BETA-GALACTOSIDASE ASSAY KITS
6.2.5.1 Ease of use and rapidity of these assays have contributed to their overall demand
6.2.6 BETA-GLUCURONIDASE ASSAY KITS
6.2.6.1 GUS reporter assays are mainly used for plant gene expression research
6.2.7 OTHER ASSAY KITS
6.3 REAGENTS
6.3.1 INCREASING DEMAND FOR HIGH-QUALITY REAGENTS IN BIOSCIENCES AND BIOTECHNOLOGY HAS DRIVEN REAGENT USE
7 REPORTER GENE ASSAYS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CELL SIGNALING PATHWAYS
7.2.1 CELL SIGNALING PATHWAYS IS THE LARGEST APPLICATION SEGMENT OF THE REPORTER GENE ASSAYS MARKET
7.3 PROMOTER STRUCTURAL AND FUNCTIONAL ANALYSIS
7.3.1 REPORTER GENE ASSAYS ALLOW FOR THE FUNCTIONAL IDENTIFICATION AND CHARACTERIZATION OF PROMOTER AND ENHANCER ELEMENTS
7.4 GENE REGULATION
7.4.1 REPORTER GENE ASSAYS ACTS AS POWERFUL TOOLS IN ANALYZING GENE REGULATIONS
7.5 PROTEIN INTERACTION
7.5.1 REPORTER GENE ASSAYS ARE USED FOR THE IDENTIFICATION AND QUANTITATIVE ANALYSIS OF PROTEIN-PROTEIN INTERACTION
8 REPORTER GENE ASSAYS MARKET, BY END USER
8.1 INTRODUCTION
8.2 ACADEMIC & RESEARCH INSTITUTES
8.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF THE REPORTER GENE ASSAYS MARKET
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.3.1 INCREASING NUMBER OF R&D ACTIVITIES TO DRIVE THE MARKET GROWTH FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.4.1 CROS TO PROVIDE AFFORDABLE OUTLETS FOR COMPANIES AND ACADEMIA TO PURSUE NEW MEDICINES
8.5 HOSPITAL & DIAGNOSTIC LABORATORIES
8.5.1 HIGH PREVALENCE OF CHRONIC DISEASES TO DRIVE THE MARKET GROWTH AMONG HOSPITAL & DIAGNOSTIC LABORATORIES
9 REPORTER GENE ASSAYS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 US dominates the North American reporter gene assays market
9.2.2 CANADA
9.2.2.1 Canada to witness the highest growth in the North American market primarily due to the increasing research activities
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Favorable funding scenario to support market growth in Germany
9.3.2 FRANCE
9.3.2.1 Increasing government investments in proteomics & genomics research to drive market growth
9.3.3 UK
9.3.3.1 Surge in the prevalence of cancer and neurological disorders is driving the adoption of reporter gene assays
9.3.4 ITALY
9.3.4.1 Growing proteomics and genomics research to drive the growth of the reporter gene assays market in Italy
9.3.5 SPAIN
9.3.5.1 Increasing private and public funding for cell-based research and the presence of a strong R&D infrastructure to drive market growth
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 China to register the highest growth in the global reporter gene assays market, primarily due to the large R&D investments in the country
9.4.2 JAPAN
9.4.2.1 Increasing incidence of chronic diseases and growing geriatric population to drive market growth
9.4.3 INDIA
9.4.3.1 Expansion of pharmaceutical companies
9.4.4 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 INCREASING NUMBER OF PROTEOMICS AND GENOMICS RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH IN THE REGION
9.6 MIDDLE EAST & AFRICA
9.6.1 SEVERAL LEADING GLOBAL PLAYERS ARE FOCUSING ON EXPANDING THEIR PRESENCE IN THE MEA REGION
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.2.1 MARKET SHARE ANALYSIS: REPORTER GENE ASSAYS MARKET
10.3 COMPETITIVE LEADERSHIP MAPPING
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 DYNAMIC DIFFERENTIATORS
10.3.4 EMERGING COMPANIES
10.4 COMPETITIVE SITUATION AND TRENDS
10.4.1 EXPANSIONS
10.4.2 ACQUISITIONS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 MERCK KGAA
11.2 THERMO FISHER SCIENTIFIC, INC.
11.3 PROMEGA CORPORATION
11.4 PERKINELMER
11.5 ABCAM PLC
11.6 BECTON, DICKINSON AND COMPANY
11.7 BIO-RAD LABORATORIES
11.8 DANAHER CORPORATION
11.9 BIOTIUM
11.10 PROMOCELL
11.11 INVIVOGEN
11.12 GENO TECHNOLOGY, INC.
11.13 GENECOPOEIA, INC.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 REPORTER GENE ASSAYS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
TABLE 2 REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 3 REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 REPORTER GENE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 5 LUCIFERASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 6 FLUORESCENT PROTEIN-RELATED ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7 SECRETED EMBRYONIC ALKALINE PHOSPHATASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 CHLORAMPHENICOL ACETYLTRANSFERASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 BETA-GALACTOSIDASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10 BETA-GLUCURONIDASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11 OTHER ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 REPORTER GENE ASSAY REAGENTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 14 REPORTER GENE ASSAYS MARKET FOR CELL SIGNALING PATHWAYS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 15 REPORTER GENE ASSAYS MARKET FOR PROMOTER STRUCTURAL AND FUNCTIONAL ANALYSIS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 REPORTER GENE ASSAYS MARKET FOR GENE REGULATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 REPORTER GENE ASSAYS MARKET FOR PROTEIN INTERACTION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 19 REPORTER GENE ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 REPORTER GENE ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 REPORTER GENE ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 REPORTER GENE ASSAYS MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 23 REPORTER GENE ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 28 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 29 US: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 30 US: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 31 US: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 32 US: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 33 CANADA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 34 CANADA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 35 CANADA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 36 CANADA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 39 EUROPE: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 EUROPE: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 41 EUROPE: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 42 GERMANY: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 43 GERMANY: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 44 GERMANY: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 45 GERMANY: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 46 FRANCE: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 47 FRANCE: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 48 FRANCE: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 49 FRANCE: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 50 UK: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 51 UK: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 52 UK: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 53 UK: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 54 ITALY: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 55 ITALY: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 ITALY: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 57 ITALY: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 58 SPAIN: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 59 SPAIN: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 60 SPAIN: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 61 SPAIN: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 62 ROE: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 63 ROE: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 64 ROE: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 65 ROE: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 66 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 67 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 68 ASIA PACIFIC: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 69 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 70 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 71 CHINA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 72 CHINA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 CHINA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 74 CHINA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 75 JAPAN: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 76 JAPAN: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 77 JAPAN: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 78 JAPAN: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 79 INDIA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 80 INDIA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 81 INDIA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 82 INDIA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 83 ROAPAC: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 84 ROAPAC: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 ROAPAC: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 86 ROAPAC: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 87 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 88 LATIN AMERICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 89 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 90 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 93 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 95 EXPANSIONS, 2016–2019
TABLE 96 ACQUISITIONS, 2016–2019
TABLE 1 REPORTER GENE ASSAYS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
TABLE 2 REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 3 REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 REPORTER GENE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 5 LUCIFERASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 6 FLUORESCENT PROTEIN-RELATED ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7 SECRETED EMBRYONIC ALKALINE PHOSPHATASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 CHLORAMPHENICOL ACETYLTRANSFERASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 BETA-GALACTOSIDASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10 BETA-GLUCURONIDASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11 OTHER ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 REPORTER GENE ASSAY REAGENTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 14 REPORTER GENE ASSAYS MARKET FOR CELL SIGNALING PATHWAYS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 15 REPORTER GENE ASSAYS MARKET FOR PROMOTER STRUCTURAL AND FUNCTIONAL ANALYSIS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 REPORTER GENE ASSAYS MARKET FOR GENE REGULATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 REPORTER GENE ASSAYS MARKET FOR PROTEIN INTERACTION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 19 REPORTER GENE ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 REPORTER GENE ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 REPORTER GENE ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 REPORTER GENE ASSAYS MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 23 REPORTER GENE ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 28 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 29 US: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 30 US: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 31 US: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 32 US: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 33 CANADA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 34 CANADA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 35 CANADA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 36 CANADA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 39 EUROPE: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 EUROPE: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 41 EUROPE: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 42 GERMANY: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 43 GERMANY: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 44 GERMANY: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 45 GERMANY: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 46 FRANCE: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 47 FRANCE: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 48 FRANCE: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 49 FRANCE: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 50 UK: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 51 UK: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 52 UK: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 53 UK: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 54 ITALY: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 55 ITALY: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 ITALY: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 57 ITALY: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 58 SPAIN: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 59 SPAIN: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 60 SPAIN: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 61 SPAIN: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 62 ROE: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 63 ROE: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 64 ROE: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 65 ROE: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 66 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 67 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 68 ASIA PACIFIC: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 69 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 70 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 71 CHINA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 72 CHINA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 CHINA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 74 CHINA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 75 JAPAN: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 76 JAPAN: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 77 JAPAN: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 78 JAPAN: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 79 INDIA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 80 INDIA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 81 INDIA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 82 INDIA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 83 ROAPAC: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 84 ROAPAC: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 ROAPAC: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 86 ROAPAC: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 87 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 88 LATIN AMERICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 89 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 90 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 93 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 95 EXPANSIONS, 2016–2019
TABLE 96 ACQUISITIONS, 2016–2019
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
FIGURE 8 REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 9 REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 10 REPORTER GENE ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE REPORTER GENE ASSAYS MARKET
FIGURE 12 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
FIGURE 13 THE US DOMINATED THE REPORTER GENE ASSAYS MARKET IN 2018
FIGURE 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2019–2024)
FIGURE 15 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 16 DRIVERS, RESTRAINTS, AND OPPORTUNITIES: REPORTER GENE ASSAYS MARKET
FIGURE 17 ASSAY KITS SEGMENT TO DOMINATE THE REPORTER GENE ASSAYS MARKET, BY PRODUCT, DURING THE FORECAST PERIOD
FIGURE 18 CELL SIGNALING PATHWAYS SEGMENT TO DOMINATE THE REPORTER GENE ASSAYS MARKET DURING THE FORECAST PERIOD
FIGURE 19 REPORTER GENE ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 20 REPORTER GENE ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 NORTH AMERICA: REPORTER GENE ASSAYS MARKET SNAPSHOT
FIGURE 22 EUROPE: REPORTER GENE ASSAYS MARKET SNAPSHOT
FIGURE 23 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET SNAPSHOT
FIGURE 24 REPORTER GENE ASSAY MARKET, BY KEY PLAYER, 2018
FIGURE 25 REPORTER GENE ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2018)
FIGURE 26 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 28 PERKINELMER: COMPANY SNAPSHOT
FIGURE 29 ABCAM PLC: COMPANY SNAPSHOT
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 31 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
FIGURE 8 REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 9 REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 10 REPORTER GENE ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE REPORTER GENE ASSAYS MARKET
FIGURE 12 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
FIGURE 13 THE US DOMINATED THE REPORTER GENE ASSAYS MARKET IN 2018
FIGURE 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2019–2024)
FIGURE 15 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 16 DRIVERS, RESTRAINTS, AND OPPORTUNITIES: REPORTER GENE ASSAYS MARKET
FIGURE 17 ASSAY KITS SEGMENT TO DOMINATE THE REPORTER GENE ASSAYS MARKET, BY PRODUCT, DURING THE FORECAST PERIOD
FIGURE 18 CELL SIGNALING PATHWAYS SEGMENT TO DOMINATE THE REPORTER GENE ASSAYS MARKET DURING THE FORECAST PERIOD
FIGURE 19 REPORTER GENE ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 20 REPORTER GENE ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 NORTH AMERICA: REPORTER GENE ASSAYS MARKET SNAPSHOT
FIGURE 22 EUROPE: REPORTER GENE ASSAYS MARKET SNAPSHOT
FIGURE 23 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET SNAPSHOT
FIGURE 24 REPORTER GENE ASSAY MARKET, BY KEY PLAYER, 2018
FIGURE 25 REPORTER GENE ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2018)
FIGURE 26 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 28 PERKINELMER: COMPANY SNAPSHOT
FIGURE 29 ABCAM PLC: COMPANY SNAPSHOT
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 31 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT
